Heterozygous Familial Hypercholesterolemia (HeFH) Latest Advances

Genetic dyslipidemias.

Journal: Annales d'endocrinologie

Published: March 22, 2026

Impact of Genetic Testing Among Patients With Familial Hypercholesterolemia on Adverse Cardiovascular Events　- The Hokuriku-Plus Familial Hypercholesterolemia Registry Study.

Journal: Circulation journal : official journal of the Japanese Circulation Society

Published: March 22, 2026

Primary care providers-initiated screening for familial hypercholesterolemia: a model proposed based on the Kordian primary prevention program for cardiovascular diseases.

Journal: Polish archives of internal medicine

Published: February 23, 2026

Update on genetics of familial hypercholesterolemia.

Journal: Current opinion in lipidology

Published: February 18, 2026

Coronary calcium scoring and risk prediction in heterozygous familial hypercholesterolemia.

Journal: Acta cardiologica

Published: February 11, 2026

Familial hypercholesterolemia in pregnancy.

Journal: Current opinion in endocrinology, diabetes, and obesity

Published: February 05, 2026

Update on familial hypercholesterolemia: An expert clinical consensus from the National Lipid Association.

Journal: Journal of clinical lipidology

Published: January 07, 2026

The evolving therapeutic landscape of PCSK9 inhibition.

Journal: Atherosclerosis

Published: January 05, 2026

Assessment of subclinical atherosclerosis with coronary calcium score in heterozygous familial hypercholesterolemia.

Journal: Acta cardiologica

Published: December 23, 2025

Efficacy of evinacumab by genotype and low-density lipoprotein receptor function in patients with homozygous familial hypercholesterolaemia: A subanalysis from the ELIPSE open-label extension study.

Journal: Atherosclerosis

Published: December 18, 2025

Genetic Testing for Children with Familial Hypercholesterolemia.

Journal: Journal of atherosclerosis and thrombosis

Published: December 17, 2025

A nationwide genetic and phenotypic spectrum of 63 probands of homozygous familial hypercholesterolemia in Taiwan.

Journal: Journal of clinical lipidology

Published: December 08, 2025

Heterozygous Familial Hypercholesterolemia (HeFH) Latest Advances

Find the Latest Research About Heterozygous Familial Hypercholesterolemia (HeFH)

Genetic dyslipidemias.

Genetic dyslipidemias.

Impact of Genetic Testing Among Patients With Familial Hypercholesterolemia on Adverse Cardiovascular Events - The Hokuriku-Plus Familial Hypercholesterolemia Registry Study.

Impact of Genetic Testing Among Patients With Familial Hypercholesterolemia on Adverse Cardiovascular Events - The Hokuriku-Plus Familial Hypercholesterolemia Registry Study.

Primary care providers-initiated screening for familial hypercholesterolemia: a model proposed based on the Kordian primary prevention program for cardiovascular diseases.

Primary care providers-initiated screening for familial hypercholesterolemia: a model proposed based on the Kordian primary prevention program for cardiovascular diseases.

Update on genetics of familial hypercholesterolemia.

Update on genetics of familial hypercholesterolemia.

Coronary calcium scoring and risk prediction in heterozygous familial hypercholesterolemia.

Coronary calcium scoring and risk prediction in heterozygous familial hypercholesterolemia.

Familial hypercholesterolemia in pregnancy.

Familial hypercholesterolemia in pregnancy.

Update on familial hypercholesterolemia: An expert clinical consensus from the National Lipid Association.

Update on familial hypercholesterolemia: An expert clinical consensus from the National Lipid Association.

The evolving therapeutic landscape of PCSK9 inhibition.

The evolving therapeutic landscape of PCSK9 inhibition.

Assessment of subclinical atherosclerosis with coronary calcium score in heterozygous familial hypercholesterolemia.

Assessment of subclinical atherosclerosis with coronary calcium score in heterozygous familial hypercholesterolemia.

Efficacy of evinacumab by genotype and low-density lipoprotein receptor function in patients with homozygous familial hypercholesterolaemia: A subanalysis from the ELIPSE open-label extension study.

Efficacy of evinacumab by genotype and low-density lipoprotein receptor function in patients with homozygous familial hypercholesterolaemia: A subanalysis from the ELIPSE open-label extension study.

Genetic Testing for Children with Familial Hypercholesterolemia.

Genetic Testing for Children with Familial Hypercholesterolemia.

A nationwide genetic and phenotypic spectrum of 63 probands of homozygous familial hypercholesterolemia in Taiwan.

A nationwide genetic and phenotypic spectrum of 63 probands of homozygous familial hypercholesterolemia in Taiwan.

Impact of Genetic Testing Among Patients With Familial Hypercholesterolemia on Adverse Cardiovascular Events　- The Hokuriku-Plus Familial Hypercholesterolemia Registry Study.

Impact of Genetic Testing Among Patients With Familial Hypercholesterolemia on Adverse Cardiovascular Events　- The Hokuriku-Plus Familial Hypercholesterolemia Registry Study.